Low Immune Activation despite High Levels of Pathogenic Human Immunodeficiency Virus Type 1 Results in Long-Term Asymptomatic Disease
- 15 August 2007
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (16) , 8838-8842
- https://doi.org/10.1128/jvi.02663-06
Abstract
Long-term asymptomatic human immunodeficiency virus (HIV)-infected individuals (LTA) usually have low viral load and low immune activation. To discern whether viral load or immune activation is dominant in determining progression to AIDS, we studied three exceptional LTA with high viral loads. HIV type 1 isolates from these LTA were as pathogenic as viruses from progressors in organ culture. Despite high viral loads, these LTA had low levels of proliferating and activated T cells compared to progressors, like other LTA. In contrast to those in progressors, HIV-specific CD4(+) T-cell responses in these LTA were maintained. Thus, low immune activation despite a high viral load preserved HIV-specific T-cell responses and resulted in a long-term asymptomatic phenotype.Keywords
This publication has 17 references indexed in Scilit:
- R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 ExpressionJournal of Virology, 2005
- Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral loadBlood, 2004
- Persistent immune activation in HIV-1 infection is associated with progression to AIDSAIDS, 2003
- Nonpathogenic SIV Infection of Sooty Mangabeys Is Characterized by Limited Bystander Immunopathology Despite Chronic High-Level ViremiaImmunity, 2003
- Reduced Levels of CD4 Cell Spontaneous Apoptosis in Human Immunodeficiency Virus–Infected Patients with Discordant Response to Protease InhibitorsThe Journal of Infectious Diseases, 2002
- CD4+T Cell Kinetics and Activation in Human Immunodeficiency Virus–Infected Patients Who Remain Viremic Despite Long‐Term Treatment with Protease Inhibitor–Based TherapyThe Journal of Infectious Diseases, 2002
- Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug usersAIDS, 2000
- Shorter Survival in Advanced Human Immunodeficiency Virus Type 1 Infection Is More Closely Associated with T Lymphocyte Activation than with Plasma Virus Burden or Virus Chemokine Coreceptor UsageThe Journal of Infectious Diseases, 1999
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohortThe Lancet, 1991